ClinicalTrials.govpublic full text
A Safety Study to Assess the Effects of Therapeutic and Supratherapeutic Exenatide Concentrations on QT Interval in Healthy Subjects
healthy subjects, diabetes, exenatide, amylin, lilly, qt interval, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 800772
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.